This site runs best with JavaScript enabled
Proton Logo
Home Page Header

ProtonDx

Certainty in Testing Times

Rapid, portable, and accurate diagnostics, where you need it.

ProtonDx is a health technology company

Contact ProtonDx

ProtonDx is launching a series of cutting‑edge diagnostic tools founded on a decade of research and development at Imperial College London.

Our vision is to develop ultra‑rapid, extremely precise, molecular testing for everyone at the point‑of‑need.

Dragonfly Diagnostic Platform

Rapid, portable, and accurate diagnostics.

Contact ProtonDx

Dragonfly combines portability, speed, high sensitivity, high specificity, and convenience to differentiate and detect multiple pathogens from a single sample in less than 30 minutes.

High quality DNA and RNA samples are extracted from nasopharyngeal swabs and prepared for testing with minimal handling, providing results equivalent to the ‘gold standard’ polymerase chain reaction test (PCR) at point‑of‑need. In addition, the Dragonfly platform provides confidence that the patient sample has been taken and tested correctly.

Dragonfly test panels are available to detect a variety of pathogens.

The Dragonfly system is a CE‑marked in vitro diagnostic medical device and complies with the current European In‑vitro Diagnostic Devices Directive (IVDD 98/79/EC).

The latest news of Dragonfly being used at the Commonwealth Games 2022 can be found here.

Dragonfly SARS‑CoV‑2 Panel

Rapid identification of SARS‑CoV‑2 where you need it.

The Dragonfly SARS‑CoV‑2 test panel is designed to help combat the ongoing COVID‑19 pandemic. It has the potential to detect current and emerging variants with PCR equivalent accuracy in under 30 minutes. As a molecular test, Dragonfly is capable of detecting low viral loads associated with an early stage in the disease cycle.

The Dragonfly system for rapid identification of SARS‑CoV‑2 is CE‑marked and commercially available as an in vitro diagnostic tool in the European Union.

Contact ProtonDx

Dragonfly Respiratory Panel

If it is not COVID‑19 what is it?

With many respiratory illnesses presenting similar symptoms, effective treatment is dependent on an accurate diagnosis. The Dragonfly respiratory test panel is designed to rapidly identify and distinguish Influenza A, Influenza B, Respiratory Syncytial Virus (RSV), and Rhinovirus as well as SARS‑CoV‑2.

The Dragonfly system for identification and differentiation of common respiratory pathogens is CE‑marked and commercially available as an in vitro diagnostic tool in the European Union.

Contact ProtonDx

Where Dragonfly makes a difference

Stay in touch:

Image

ProtonDx

Certainty in testing and confidence in our daily life.